Brief: Enorama Pharma April-June Operating Loss Widens To SEK 3.1 Million
15/08/2018 07:53
Aug 15 (Reuters) - ENORAMA PHARMA AB ERMA.ST :
* APRIL-JUNE OPERATING LOSS SEK 3.1 MILLION VERSUS LOSS SEK
1.8
MILLION YEAR AGO
* APRIL-JUNE NET SALES SEK 1.7 MILLION VERSUS SEK 0 YEAR AGO
Source text for Eikon: ID:nWkr44Vrv
Further company coverage: ERMA.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Enorama Pharma AB
See all newsBrief: Enorama Pharma Signs Agreements For Nic-S Tobacco-Free White Snus
Brief: Enorama Pharma Gets FDA Statement In Ongoing US Court Proceedings
Brief: Enorama Pharma Q2 Operating Loss SEK 11.7 Mln
Brief: FDA Upholds Refuse-To-File Decision On Enorama Pharma's PMTA Applications
Brief: Enorama Pharma Names Amy Walker New Interim CEO